Skip to main content
. 2024 Nov 25;168(6):e240253. doi: 10.1530/REP-24-0253

Table 3.

Fertility preservation (semen analysis or TESE outcomes) in TGD people with testes.

Age group GAHT exposure status Technique used Results References
Adult No prior GnRHa and GAHT exposure Semen collection Poor semen parameters compared to referenced cisgender samples Adeleye et al. (2019b); Rodriguez-Wallberg et al. (2021a); Hamada et al. (2015); Barda et al. (2023); de Nie et al. (2020); Li et al. (2018)
Poor semen parameter in post-thawed samples de Nie et al. (2020); Hamada et al. (2015)
With continued GnRHa/GAHT at collection Semen collection Low semen parameters compared to previously-used GAHT and GAHT-naïve Adeleye et al. (2019b)
Stop GnRHa/GAHT at collection Semen collection Semen parameters poorer than GAHT-naïve TGD samples Rodriguez-Wallberg et al. (2021a)
Semen parameters comparable with GAHT-naïve TGNB samples. Adeleye et al. (2019b); Barda et al. (2023)
Semen parameters higher than continuously-used GAHT Adeleye et al. (2019b)
Semen collection or testicular sperm extraction Natural conceptions reported in 3/9 cases; Viable sperm retrieved from all 9 cases by semen collection or testicular sperm extraction. de Nie et al. (2023)
Peripubertal No prior GnRHa and GAHT exposure Semen collection (16-24-year-old TGDs) Normal semen parameters except for low percentage (3%) of normal morphology compared to normal reference per Modified Kruger criteria (>13%) in group with mean age 19.5 Barnard et al. (2019)
Testicular sperm extraction (13-17-year-old TGDs) Successful sperm retrieval (68%, 17/25) Peri et al. (2021)
With continued GnRHa/GAHT at collection No data No data No data
Stop GnRHa/GAHT at collection Semen collection (age 17.5 at GnRHa initiation, age 18 at retrieval, n=1) 12 sperm (2 motile) found 3 months after suspending GnRHa; Normal semen sample 5 months after suspending GnRHa Barnard et al. (2019)
Semen collection (age 18 at initiation, age 19 at retrieval, n=1) Azoospermic at 4 months after suspending GAHT Barnard et al. (2019)

GnRHa, Gonadotropin releasing hormone agonist; GAHT, gender-affirming hormone therapy